- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Ivacaftor Placebo
Total 53646 results
-
Massachusetts General HospitalTerminatedDiabetes | Cystic Fibrosis
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationCompletedCystic FibrosisUnited States
-
Vertex Pharmaceuticals IncorporatedActive, not recruitingCystic FibrosisUnited States, United Kingdom, Canada, Australia, Germany
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Canada, Australia, Ireland, United Kingdom
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Canada, United Kingdom, Australia, Ireland
-
Vertex Pharmaceuticals IncorporatedApproved for marketing
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisBelgium, United Kingdom, Australia, Germany
-
Vertex Pharmaceuticals IncorporatedApproved for marketing
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationCompletedCystic FibrosisUnited Kingdom, United States, Canada
-
University of British ColumbiaRecruiting
-
University of Alabama at BirminghamRecruitingCystic FibrosisUnited States
-
University Hospital, Strasbourg, FranceCompletedCystic Fibrosis Homozygous for Phe 508 Del CFTR | Glucose Intolerance or Newly Diagnosis DiabetesFrance
-
Carmel Medical CenterCompleted
-
Vertex Pharmaceuticals IncorporatedActive, not recruitingCystic FibrosisSpain, Belgium, Netherlands, France, Canada, Germany, Sweden, Switzerland, Italy, Czechia, Portugal, Austria, Hungary, Norway, Poland
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisFrance, Spain, Belgium, Netherlands, Australia, Italy, Czechia
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisBelgium, Spain, Australia, Canada
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, United Kingdom, Canada, Australia, Germany
-
University of California, Los AngelesUniversity of Iowa; Children's Hospital Colorado; University of Kansas Medical... and other collaboratorsRecruitingChronic Rhinosinusitis (Diagnosis) | Cystic Fibrosis | Olfactory Disorder | Cystic Fibrosis in Children | Olfactory ImpairmentUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisCanada, France, United Kingdom, Israel, Australia, Spain, Germany, Netherlands, Denmark, Switzerland
-
CHC MontLégiaActive, not recruiting
-
Vertex Pharmaceuticals IncorporatedTerminatedCystic FibrosisUnited States
-
Emory UniversityNational Heart, Lung, and Blood Institute (NHLBI); Cystic Fibrosis FoundationRecruiting
-
Vertex Pharmaceuticals IncorporatedApproved for marketing
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States
-
Sonya HeltsheUniversity of Alabama at Birmingham; University of Washington; Cystic Fibrosis...Recruiting
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Canada, Australia, Ireland, United Kingdom
-
University of Alabama at BirminghamCompleted
-
University of British ColumbiaRecruiting
-
Istituto Auxologico ItalianoRecruiting
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Canada
-
Jennifer Taylor-CousarCystic Fibrosis FoundationRecruiting
-
Vertex Pharmaceuticals IncorporatedTerminatedCystic FibrosisUnited States, Spain, Ireland, Australia, Israel, United Kingdom, Germany, Canada, Denmark, Poland, Switzerland
-
University Hospital, Strasbourg, FranceNot yet recruiting
-
Vertex Pharmaceuticals IncorporatedModerna, IncRecruitingCystic FibrosisUnited States, United Kingdom, Australia, Canada
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Canada
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Australia, Canada, United Kingdom, Germany, Belgium, Austria, Ireland, Italy, France
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Spain, United Kingdom, New Zealand, Israel, Australia, Ireland, Germany, Sweden, Czechia, Portugal, Hungary
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, France, United Kingdom, Germany, Belgium, Denmark, Canada, Australia, Sweden
-
Vertex Pharmaceuticals IncorporatedCompletedHealthy | Hepatic ImpairmentSlovakia, Czech Republic
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, United Kingdom, Belgium, Netherlands, France, Denmark, Israel, New Zealand, Australia, Ireland, Sweden, Canada, Germany, Poland, Switzerland, Italy, Austria, Hungary, Greece, Norway
-
Nottingham University Hospitals NHS TrustActive, not recruitingCystic FibrosisUnited Kingdom
-
University of Kansas Medical CenterNational Institute on Aging (NIA)Completed
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationCompleted
-
University of Erlangen-Nürnberg Medical SchoolRecruitingCystic FibrosisGermany
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationCompletedCystic FibrosisUnited States, Canada, Australia, Ireland, France, United Kingdom, Germany, Czech Republic
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationCompletedStudy of Ivacaftor in Cystic Fibrosis Subjects Aged 6 to 11 Years With the G551D Mutation (ENVISION)Cystic FibrosisUnited States, Australia, Canada, France, Germany, Ireland, United Kingdom
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationCompletedCystic FibrosisUnited States, United Kingdom
-
Hannover Medical SchoolHeidelberg University; University of GiessenCompleted
-
Assistance Publique - Hôpitaux de ParisVaincre la MucoviscidoseCompletedCystic FibrosisFrance